Biotech multinational Horizon Therapeutics have announced plans to develop a new facility that will create 350 new medical technology jobs in Co Waterford.
The company, which purchased a manufacturing facility from EirGen Pharma in IDA Ireland’s Business Park in June 2021, have submitted a planning application to expand a development and manufacturing facility.
They’re planning to add 320 thousand square feet to the existing factory at the IDA Business Park.
The facility will provide new drug substance biologics development and manufacturing capabilities, adding about 320,000 sq ft to its current 44,000 sq ft drug product (fill-finish) biologics facility.
Horizon Therapeutic’s global headquarters have been located in Dublin since 2014.
“As we grow as a global biotechnology company, it is important to continue to invest in our development and manufacturing capabilities to supplement our current network of contract manufacturing organizations to maintain flexibility over our production and supply,” said Tim Walbert, chairman, president and chief executive officer, Horizon.
“The planned expansion to add this drug substance facility is important to the long-term growth of our commercial and pipeline biologics as well as our commitment to Ireland, he said.
A multinational biotechnology company,Horizon is focused to the research, development, and commercialization of medicines for patients suffering from rare, autoimmune, and very inflammatory diseases.